Emergent BioSolutions (EBS) Tops Q1 EPS by 23c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.55 -3.68%
EPS Growth %: -138.7%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -138.7%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.16, $0.23 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $111 million versus the consensus estimate of $101.83 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- RBC Capital Reiterates Sector Perform Rating on ExxonMobil (XOM)
- Super Micro Computer rises on AI server market optimism
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
